Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer-Reference-Cited by-同舟云学术

Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple‐negative breast cancer

Published:2022-10-21 Issue:5 Volume:12 Page:5846-5858
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Zhu Yanhui¹,Zhang Hongfei¹,Pan Chaohu²³,He Gao¹,Cui Xiaoli³,Yu Xiafei¹,Zhang Xiaoqiang¹,Wu Dongfang³,Yang Junzhe¹,Wu Xian¹,Luo Haitao³^ORCID,Liu Xiaoan¹

Affiliation:

1. Department of Breast Surgery The First Affiliated Hospital of Nanjing Medical University Nanjing Jiangsu China

2. The First Affiliated Hospital Jinan University Guangzhou Guangdong China

3. Department of Medicine YuceBio Technology Co., Ltd Shenzhen Guangdong China

Funder

National Natural Science Foundation of China

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5372